Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Inbal

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experienceA Lubetsky, U Martinowitz, J Luboshitz, et al.
Cancer|January 1, 1987
Lymphocyte urosynthase in non-Hodgkin's lymphoma. An indicator of disease extensivenessA Inbal, M Modan, Z Weitz, et al.
Thrombosis Research|May 29, 2002
Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrinsR Dardik, B Shenkman, I Tamarin, et al.
Thrombosis and Haemostasis|March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand diseaseA Lubetsky, S Schulman, D Varon, et al.
Journal of Thrombosis and Haemostasis : JTH|September 30, 2014
Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiencyB Kerlin, B Brand, A Inbal, et al.
Transactions of the American Clinical and Climatological Association|July 6, 2000
Nitric oxide insufficiency and arterial thrombosisJ Loscalzo, J Freedman, A Inbal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 4, 2008
Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classificationS M B Hashemi Soteh, J Anson, A Inbal, et al.
Stroke|June 3, 2000
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in childrenG Kenet, S Sadetzki, H Murad, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated familiesA Vysokovsky, R Saxena, M Landau, et al.
British Journal of Haematology|July 1, 1992
Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cellsB Wilbourn, P Harrison, A Lawrie, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 30, 2002
Efficacy and safety of a factor VIII-von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experienceA Lubetsky, U Martinowitz, J Luboshitz, et al.
Cancer|January 1, 1987
Lymphocyte urosynthase in non-Hodgkin's lymphoma. An indicator of disease extensivenessA Inbal, M Modan, Z Weitz, et al.
Thrombosis Research|May 29, 2002
Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrinsR Dardik, B Shenkman, I Tamarin, et al.
Thrombosis and Haemostasis|March 4, 1999
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand diseaseA Lubetsky, S Schulman, D Varon, et al.
Journal of Thrombosis and Haemostasis : JTH|September 30, 2014
Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiencyB Kerlin, B Brand, A Inbal, et al.
Transactions of the American Clinical and Climatological Association|July 6, 2000
Nitric oxide insufficiency and arterial thrombosisJ Loscalzo, J Freedman, A Inbal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 4, 2008
Re-evaluation of three Israeli families initially diagnosed with type 1 von Willebrand disease in light of the ISTH update on von Willebrand factor pathophysiology and classificationS M B Hashemi Soteh, J Anson, A Inbal, et al.
Stroke|June 3, 2000
Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in childrenG Kenet, S Sadetzki, H Murad, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated familiesA Vysokovsky, R Saxena, M Landau, et al.
British Journal of Haematology|July 1, 1992
Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cellsB Wilbourn, P Harrison, A Lawrie, et al.
Pageof 7